Stryker Corporation had a decent result in the quarter and the company posted an increase in organic sales growth which was driven by double-digit growth from its Neuro-technology and MedSurg businesses. Because of the pandemic, there has been a softer sale in the spine, knee, and hip. A slowdown in deferrable measures mainly impacted the US and declined throughout the quarter. Though the company’s implant businesses were challenged, the company’s capital products performed better than its MedSu ....
25 May 2022
Stryker Corporation: Business Strategy & Key Growth Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (05/22)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Stryker Corporation: Business Strategy & Key Growth Drivers, Financial Forecasts, DCF & Comparables Valuation, ESG & Other Risks (05/22)
- Published:
25 May 2022 -
Author:
Ishan Majumdar -
Pages:
25
Stryker Corporation had a decent result in the quarter and the company posted an increase in organic sales growth which was driven by double-digit growth from its Neuro-technology and MedSurg businesses. Because of the pandemic, there has been a softer sale in the spine, knee, and hip. A slowdown in deferrable measures mainly impacted the US and declined throughout the quarter. Though the company’s implant businesses were challenged, the company’s capital products performed better than its MedSu ....